| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285915 | Parkinsonism & Related Disorders | 2016 | 7 Pages |
Abstract
Standard vMRI measurements are sensitive to disease progression in large, multicenter PSP clinical trials, but are not well correlated with clinical changes. vMRI changes may be useful as supportive endpoints in PSP trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Richard M. Tsai, Iryna Lobach, Jee Bang, Jennifer L. Whitwell, Matthew L. Senjem, Clifford R. Jr., Howard Rosen, Bruce Miller, Adam L. Boxer, AL-108-231 Investigators AL-108-231 Investigators,